Compare · CCM vs CHE
CCM vs CHE
Side-by-side comparison of Concord Medical Services Holdings Limited (CCM) and Chemed Corp (CHE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CCM and CHE operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $5.66B, about 264.4x CCM ($21.4M).
- Over the past year, CCM is down 28.3% and CHE is down 25.7% - CHE leads by 2.6 points.
- CHE has been more active in the news (11 items in the past 4 weeks vs 3 for CCM).
- CHE has more recent analyst coverage (6 ratings vs 0 for CCM).
- Company
- Concord Medical Services Holdings Limited
- Chemed Corp
- Price
- $5.02+1.41%
- $423.21-0.74%
- Market cap
- $21.4M
- $5.66B
- 1M return
- +34.58%
- -0.58%
- 1Y return
- -28.29%
- -25.71%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2024
- News (4w)
- 3
- 11
- Recent ratings
- 0
- 6
Concord Medical Services Holdings Limited
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in Network and Hospital segments. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. It also offers other treatments and diagnostic services comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, it offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as tele-consulting services; and sells medical equipment. Additionally, the company establishes the Beijing Proton Medical Center that provides radiotherapy treatment options to cancer patients; and other specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of June 30, 2019, it operated a network of 30 centers based in 20 hospitals in 20 cities across 13 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China.
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest CCM
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025
- SEC Form 20-F filed by Concord Medical Services Holdings Limited
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- SEC Form 3 filed by new insider Yang Jianyu
- SEC Form 3 filed by Concord Medical Services Holdings Limited
- SEC Form 3 filed by Concord Medical Services Holdings Limited
- SEC Form 3 filed by Concord Medical Services Holdings Limited
Latest CHE
- Director Walsh George J Iii sold $218,915 worth of Capital Stock (500 units at $437.83), decreasing direct ownership by 13% to 3,209 units (SEC Form 4)
- Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Walsh George J Iii was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,709 units (SEC Form 4)
- Director Mount John Meredith Jr. was granted 386 units of Capital Stock, increasing direct ownership by 42% to 1,316 units (SEC Form 4)
- Director Mccarthy Eileen P was granted 386 units of Capital Stock, increasing direct ownership by 45% to 1,241 units (SEC Form 4)
- Director Lindell Andrea R was granted 386 units of Capital Stock, increasing direct ownership by 7% to 5,925 units (SEC Form 4)
- Director Heaney Christopher J was granted 386 units of Capital Stock, increasing direct ownership by 16% to 2,775 units (SEC Form 4)
- Director Grace Patrick P was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,723 units (SEC Form 4)
- Director Delyons Ron was granted 386 units of Capital Stock, increasing direct ownership by 23% to 2,052 units (SEC Form 4)
- Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend